Head to Head Survey: FitLife Brands (NASDAQ:FTLF) vs. Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ)

Rock Creek Pharmaceuticals (OTCMKTS:RCPIQGet Free Report) and FitLife Brands (NASDAQ:FTLFGet Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Rock Creek Pharmaceuticals and FitLife Brands’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Rock Creek Pharmaceuticals N/A N/A N/A
FitLife Brands 13.38% 29.15% 15.31%

Analyst Ratings

This is a summary of recent recommendations and price targets for Rock Creek Pharmaceuticals and FitLife Brands, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rock Creek Pharmaceuticals 0 0 0 0 0.00
FitLife Brands 0 0 1 1 3.50

FitLife Brands has a consensus price target of $40.00, indicating a potential upside of 31.75%. Given FitLife Brands’ stronger consensus rating and higher possible upside, analysts plainly believe FitLife Brands is more favorable than Rock Creek Pharmaceuticals.

Insider and Institutional Ownership

2.3% of FitLife Brands shares are owned by institutional investors. 0.9% of Rock Creek Pharmaceuticals shares are owned by company insiders. Comparatively, 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Rock Creek Pharmaceuticals and FitLife Brands”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Rock Creek Pharmaceuticals N/A N/A N/A N/A N/A
FitLife Brands $60.68 million 2.30 $5.30 million $1.69 17.96

FitLife Brands has higher revenue and earnings than Rock Creek Pharmaceuticals.

Summary

FitLife Brands beats Rock Creek Pharmaceuticals on 10 of the 10 factors compared between the two stocks.

About Rock Creek Pharmaceuticals

(Get Free Report)

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.

About FitLife Brands

(Get Free Report)

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

Receive News & Ratings for Rock Creek Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rock Creek Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.